QA: Therapeuticsmd Inc in us_pharma/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000025743_2013_Therapeuticsmd_Inc.pdf

Logs

info NetIncome node detected by revenue/expenses heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'OperatingIncomeLoss'}

Graph

Absolute values for 0000025743, Therapeuticsmd Inc

  xvar xval
0 AssetsCurrent 4,527,263
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 65,673
3 remainder_Assets 1,225,159
4 LiabilitiesCurrent 3,511,988
5 LiabilitiesNoncurrent 3,739,235
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 14,069,701
9 ResearchAndDevelopmentExpense 4,492,362
10 remainder_Expenses 1,404,373
11 remainder_Revenues 3,818,013
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 5,818,095
1 Liabilities 7,251,223
2 Expenses 19,966,436
3 Revenues 3,818,013
4 StockholdersEquity -1,433,128
5 NetIncome -16,148,423
6 ComprehensiveNetIncome -16,148,423
7 BaseVar 18,426,884
8 EconomicCapitalRatiobeforeLimitedLiability -2.95
9 EconomicCapitalRatio 0.703

Edgar->Model Mapping

Feature Distribution

Change over Time